Background Nesiritide is approved in the United States for early relief of dyspnea in patients
with acute heart failure. Previous meta-analyses have raised questions regarding renal …

Background— Patients with symptomatic chronic heart failure (CHF) and reduced left
ventricular ejection fraction (LVEF) have a high risk of death and hospitalization for CHF …

Background— Oxidative stress may contribute to heart failure (HF) progression. Inhibiting
xanthine oxidase in hyperuricemic HF patients may improve outcomes. Methods and Results…

Background: Limited comparative studies assessing the health‐related quality of life (HRQL)
in heart failure (HF) patients with preserved vs. low ejection fraction (LVEF) have been …

“A 57-year-old patient with a history of heart failure states that she began experiencing
worsening shortness of breath 4 days prior to admission, with lower extremity edema developing …

Importance The use of sacubitril/valsartan is not endorsed by practice guidelines for use in
patients with New York Heart Association class IV heart failure with a reduced ejection …

Objectives : The goal of this study was to compare the prognostic efficacy of the 6-min walk (6MW)
and cardiopulmonary exercise (CPX) tests in stable outpatients with chronic heart …

Pulse pressure, an indirect measure of vascular stiffness and pulsatile load, predicts clinical
events in congestive heart failure (CHF), suggesting that abnormal pulsatile load may …

Systolic hypertension is associated with increased pulse pressure (PP) and increased risk
for adverse cardiovascular outcomes. However the pathogenesis of increased PP remains …

Objectives : We explored the incidence and predictors of hyperkalemia in a broad population
of heart failure patients. Background : When used in optimal doses to treat patients with …